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Exposures to two commercial nanoﬁlm spray products (NFPs),
a ﬂoor sealant (NFP 1) and a coating product for tiles (NFP 2),
were investigated for airway irritation, airway inﬂammation, and
lung damage in a mouse inhalation model. The particle exposure
was characterized by particle number, particle size distribution,
and gravimetric analysis. BALB/cJ mice were exposed for 60 min
to the aerosolized products at 3.3–60 mg/m
3 (10
5–10
6 ﬁne
particles/cm
3) measured in the breathing zone of the mice. Lung
inﬂammation and lung damage were assessed by study of
bronchoalveolar lavage ﬂuid (BALF) cytology, protein in BALF,
and histology. Mass spectral analysis showed that NFP 1 and NFP 2
contained hydrolysates and condensates of a perﬂuorosilane and
alkylsilane, respectively. NFP 1 induced a concentration-dependent
decrease of the tidal volume lasting for at least 1 day. Exposure
concentrations above 16.1 mg/m
3 (2.1 3 10
6 ﬁne particles/cm
3) gave
rise to signiﬁcant increases of protein level in BALF and reduced
body weight, and histological examination showed atelectasis,
emphysema, and hemorrhages. A narrow interval between the no-
effect level (16.1 mg/m
3) and the lethal concentrations (18.4 mg/m
3)
was observed. The alkylsilane-based product (NFP 2) had no effect
at the concentrations studied. Experiments with different types of
perﬂuorinated silanes and alkylsiloxanes showed that the toxic
effects did not arise solely from the perﬂuorination. The number of
free hydroxyl groups in the silanes/alkylsiloxanes was also critical
for the toxicity.
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Nanoﬁlm spray products (NFPs) are a relatively new type of
surface coatings for industrial and domestic use. Most of the
NFPs induce nonstick properties when applied to surfaces. The
NFPs are available for a wide range of surfaces, e.g., bathroom
tiles, ﬂoors, textiles, and windows. The NFPs are sprayed onto
a surface, and a thin (nano) ﬁlm is formed by self-organization
during evaporation of the solvent. A literature search in various
patent databases yielded some information about the pro-
duction of coating compositions that induce similar properties
to a treated surface as the ones mentioned for the NFPs above
(Brueck et al., 2003; Fries et al., 2001; Gross et al., 2003;
Schmidt et al., 1997). These patents indicate that NFPs may be
based on organo-functionalized silanes (e.g., ﬂuorinated) and,
in some cases, nanoparticles of for example silica or titantia.
These silanes are ‘‘activated’’ through controlled hydrolysis
and condensation reactions, which enable the formation of
a self-assembling ﬁlm during evaporation of the solvent, thus
inducing the desired properties to the treated surface (Brinker,
2004; Hench and West, 1990; Schmidt, 2006; Sepeur, 2008).
The result is an interconnected rigid network of functionalized
organosiloxanes. The process is similar to the preparation of
silica sols by polymerization of silicon alkoxides by addition of
water and an acid catalyst (Hench and West, 1990).
The identity and concentration of all chemicals in the
commercial products are seldom available from the product
information, e.g., materials safety data sheets (MSDS).
Consequently, the current knowledge of the chemical compo-
sition of the products is limited and insufﬁcient for risk
assessment.Recently, itwas concluded on thebasis of102 cases
with waterprooﬁng spray products that ‘‘no threshold could be
found to deﬁne a safe level of exposure’’ (Vernez et al., 2006).
Furthermore, it was concluded that improvement of the
occupationalandenvironmentalconditionsprovidedinsufﬁcient
prevention of future outbreaks of waterprooﬁng spray toxicity
because the cause-effect relationship is unknown.
A number of cases have been reported worldwide after
application of spray products to leather and textiles (Burkhart
et al.,1 9 9 6 ; Heinzer et al., 2004; Laliberte ´ et al., 1995;
Lazor-Blanchet et al., 2004; Okonek et al., 1983; Vernez et al.,
2006; Woo et al., 1983). The symptoms were dyspnea, breast
pain, coughing, headache, and fever; some may have a severe
reaction, e.g., lung inﬂammation with pulmonary edema and
hemorrhage and reduced alveolar oxygen uptake resulting in
reduced blood oxygen tension. Clusters of cases have been
observed after reformulation of products, e.g., substitution of
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Yamashita and Tanaka, 1995). It has been argued that the
common solvents in the product and particles per se were
unlikely causative agents of the reported symptoms (Vernez
et al., 2006; Yamashita and Tanaka, 1995). Recently, at least
153 severe cases with rapidly developing reactions have been
registered by the Federal Institute for Risk Assessment in
Germany. The individuals used a so-called Magic Nano spray
product for coating glass and ceramic tiles (Pauluhn et al.,
2008). Major symptoms were vigorous cough and dyspnea. In
some cases, lung edema was also conﬁrmed by exposure of
rodents to the same product (Pauluhn et al., 2008). The
causative agents, however, have not been identiﬁed.
It has been postulated that perﬂuorinated silanes may alter
the surface properties of the lung lining ﬂuid, e.g., by
increasing the surface tension of the lung lining ﬂuid
(Yamashita and Tanaka, 1995). This could counteract the
effects of lung surfactants resulting in alveolar collapse with
the consequence of a cascade of potential lung-damaging
effects (Vernez et al., 2006; Yamashita and Tanaka, 1995).
This is partly supported by the fact that the perﬂuorinated
polymers appear to be potentially more toxic than non-
ﬂuorinated alkylsiloxanes (Yamashita and Tanaka, 1995).
Identiﬁcation of common molecular structures of toxic
substances in NFPs may allow substitution with less toxic
compounds and thus prevent future outbreaks. Additionally,
signiﬁcant exposure to both surface-active chemicals and very
ﬁne particles formed in the air during application is possible
during the use of these products (Nørgaard et al., 2009). Taken
together, these observations prompted us to investigate two
common commercial NFPs for sealing surfaces: one with and
one without perﬂuorinated silanes/alkylsiloxanes. This was
carried out by the use of a mouse inhalation model that allows
assessment of effects in the upper and lower airways (e.g.,
Kuwabara et al., 2007). Toxic effects were evaluated by
analysis of pulmonary function, inﬂammatory cells in bron-
choalveolar lavage ﬂuids (BALFs), and histopathology. The
particle exposure was monitored, and the products were subject
to detailed chemical characterization to enable identiﬁcation of
the potential causative agents.
MATERIALS AND METHODS
Animals. Inbred male BALB/cA mice aged 5–6 weeks, weight 24.1 ± 1.7 g,
were purchased from Taconic M&B (Ry, Denmark) and were housed in
polypropylene cages (380 3 220 3 150 mm) with pinewood sawdust bedding
(Lignocel S8; Brogaarden, Denmark). The cages, housing up to 10 mice each,
were furnished with bedding materials, gnaw sticks, and cardboard tubes. The
photoperiod was from 6:00 A.M. to 6:00 P.M., and the temperature and mean
relative humidity in the animal room were 21 C ± 0.2 Ca n d5 5± 5% (SD),
respectively. Cages were sanitized twice weekly. Food (Altromin no. 1324;
Altromin, Lage, Germany) and municipal tap water were available ad libitum.
Treatment of the animals followed procedures approved by The Animal
Experiment Inspectorate, Denmark (No. 2006/561-1123-C3).
Chemicals. Ethanol (99.9%), 2-propanol (99.9%), formic acid (98–100%),
1H,1H,2H,2H-perﬂuorooctyl triethoxysilane (98%), and dodecyl trimethoxysi-
lane (95%) were obtained from Sigma-Aldrich (Brøndby, Denmark).
Bis-(1H,1H,2H,2H-perﬂuorooctyl) tetramethyldisiloxane (95%) was obtained
from Apollo Scientiﬁc (Cheshire, UK). Denaturated ethanol (93%) was
purchased from Borup Kemi (Borup, Denmark).
Nanoﬁlm products. Two types of NFPs were investigated in this study:
one for coating of nonabsorbing ﬂoor materials (NFP 1) and one for coating of
ceramic tiles (NFP 2). Both products are delivered in pump spray bottles.
According to the MSDS supplied by the distributor, NFP 1 contains 2-propanol
(solvent) and unspeciﬁed ﬂuorosilane and NFP 2 contains ethanol and methanol
(solvents) and unspeciﬁed alkylsilane. The coating of surfaces requires 10–40 g/m
2
depending on product type.
Chemical analysis using electrospray ionization mass spectrometry (ESI-
MS) showed that NFP 1 and NFP 2 contained hydrolysates and condensates of
1H,1H,2H,2H-perﬂuorooctyl triisopropoxysilane and hexadecyl trimethoxysi-
lane, respectively, see Figure 1. When applied to a surface, OH-groups will
condense with each other forming a polysiloxane network. Excess silane
and alkylsiloxane are wiped from the treated surface afterward, leaving
a thin hydrophobic layer. Further details of the chemical analysis will be
published elsewhere (Nørgaard, Wolkof, and Lauritsen, in preparation). Gas
chromatography-mass spectrometry analysis of the emitted volatile organic
compounds during spraying showed chloroacetones and 1H,1H,2H,2H-
perﬂuorooctyl triisopropoxysilane from NFP 1 and several small aliphatic
ketones from NFP 2 (Nørgaard et al., 2009).
The concentrations of silanes in NFP 1 and NFP 2 were estimated in the
followingway:1mlNFPwastransferredtoa2-mlglassvialandpurgedatambient
temperature to dryness by a gentle stream of nitrogen (purity 5.0, i.e. >99.999%).
The mass of the nonvolatile fraction was determined gravimetrically in
quadruplicate. NFP 1 and NFP 2 contained 1.1 ± 0.1% and 1.5 ± 0.1% silane by
weight, respectively.
Preparation of synthetic ﬂoor sealant, NFP 1. To verify the effects
observed for NFP 1, a synthetic NFP 1 was prepared from 1H,1H,2H,2H-
perﬂuorooctyl triethoxysilane. In addition, this permitted an evaluation of the
role of free hydroxyl groups for the toxicity of perﬂuorinated silanes/
alkylsiloxanes; 1.5, 2.25, or 3.0 mmol of water (0.5, 0.75, and 1.0 mol water
added for each hydrolyzable group, respectively) and 0.3 mmol formic acid was
added to 1.0 mmol of 1H,1H,2H,2H-perﬂuorooctyl triethoxysilane in a 2.5-ml
plastic vial. Furthermore, 100 ll of ethanol was added before the mixtures were
shaken gently for 30 min and then allowed to stand at room temperature for
2 days resulting in clear homogenous solutions. The mixtures were then diluted
with ethanol until 1.2% solutions were obtained. The solutions were stored in
Teﬂon ﬂasks at room temperature until use. Samples for ESI-MS experiments
were taken to verify the degree of condensation/hydrolysis.
A clear tendency could be observed by adding 1.5, 2.25, and 3 mmol of
water, respectively, where the degree of hydrolysis increased with the addition
of water, thus leading to more free hydroxyl groups.
Generation of test atmospheres and particle characterization. The inlet
ﬂow rates of the NFPs used in the exposures are shown in Table 1. The mice
were exposed to NFP 1, NFP 2, synthesized NFP 1, and solutions (1.2%)
of 1H,1H,2H,2H-perﬂuorooctyl triethoxysilane (perﬂuorosilane) and
bis(1H,1H,2H,2H-perﬂuorooctyl) tetramethyldisiloxane (perﬂuorodisiloxane) in
ethanol, see Figure 1.T h eN F P s ,c h e m i c a l s ,a n ds o l v ent controls were aerosolized
by continuously injecting the solutions from a glass syringe to a Pitt no. 1 jet
nebulizer (Wong and Alarie, 1982) by means of an infusion pump (New England
Medical Instruments Inc., Medway, MA). The exposure airstream was sub-
sequently led through a Vigreaux column to ensure homogenous mixing and
directed into a 20-l exposure chamber of stainless steel with a hemispherical lid and
bottom made of glass resulting in an air exchange rate of 1.5 min
 1 (29.6 l/min).
Outlet air was passed through a series of particle and active coal ﬁlters
before exhaust to the atmosphere. 2-Propanol and denaturated ethanol were
used as solvent controls for NFP 1 and NFP 2, respectively.
The particle exposure was measured by the use of four different types of
particle measurements: The size distribution of nanoparticles was measured
using a Fast Mobility Particle Sizer (FMPS; TSI Model 3091; Shoreview, MN),
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midpoints ranging from 6.04 to 523.3 nm.
The FMPS was operated at room temperature, and sampling was conducted
through the standard FMPS cyclone Model 1031083 (d50 ¼ 1 lm). Coarser
particles were measured using an Aerodynamic Particle Sizer (APS; TSI Model
3321), which measures the aerodynamic particle size (Da) of particles in
51 diameter classes with midpoints ranging from 0.542 to 18.4 lm.
A Condensation Particle Counter (CPC; Grimm Model 5.403; Douglasville,
GA) was used for the measurement of the total number of ﬁne particles (4.5 nm
[D50, veriﬁed with tungsten oxide] to >3 lm). Particles were sampled at
FIG. 1. Silanes and alkylsiloxanes of 1H,1H,2H,2H-perﬂuorooctyl triisopropoxysilane (NFP 1) and hexadecyl triethoxysilane (NFP 2). A nonhydrolyzed
silane and a monohydrolyzed disiloxane are shown for each of the two NFPs.
TABLE 1
Particle Concentration Data for Exposure Tests of (a) Floor Sealant (NFP 1) and (b) Tile Coating (NFP 2). Concentrations in Bold Are
Used for In Vivo Exposure; Concentrations Marked With Asterisk Are Calculated. See the ‘‘Materials and Methods’’ Section for Details
Inlet ﬂow
rate (ml/min)
Particle concentration (n/cm
3) Mass concentration in exposure chamber (mg/m
3)
CPC FMPS APS FMPS þ APS Filter
(a)
0.01 1.4Eþ05 ± 1.0Eþ04 0.1 ± <0.1 0.4 ± <0.1 0.5 ± 0.1 0.5*
0.05 6.8E105 ± 6.1E104 1.4 ± <0.1 2.6 ± <0.1 4.0 ± 0.1 3.3 ± 0.7
0.075 1.0Eþ06 ± 7.2Eþ04 2.2 ± 0.1 3.8 ± 0.2 6.0 ± 0.3 5.9*
0.1 1.5Eþ06 ± 1.1Eþ05 3.2 ± 0.1 4.9 ± 0.2 8.1 ± 0.3 8.5 ± 2.4
0.2 2.5E106 ± 2.0E105 6.7 ± 0.2 9.9* 16.6* 15.7 ± 1.2
0.21 2.1E106* 10.1 ± 0.2 10.4* 20.5* 16.1*
0.23 2.3E106* 10.2* 11.3* 21.5* 18.4*
0.3 2.5E106* 13.3* 14.7* 28.0* 24.4*
0.5 4.6E106* 22.1* 24.7* 46.8* 42.4 ± 1.1
(b)
0.01 1.7Eþ05 ± 1.2Eþ04 0.2 ± <0.1 0.7 ± 0.1 0.9 ± 0.1 1.1*
0.05 5.4Eþ05 ± 3.9Eþ04 1.3 ± <0.1 3.3 ± 0.3 4.6 ± 0.3 3.3 ± 0.1
0.075 8.5Eþ05 ± 6.1Eþ04 2.2 ± <0.1 4.4 ± 0.5 6.6 ± 0.5 9.4*
0.2 1.9E106* 5.5* 12.3* 17.8* 33.2 ± 7.3
0.5 3.1E106 ± 2.2E105 14.9* 30.7* 45.6* 60.0 ± 2.5
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(length 10–15 cm) and 1/4’’ conducting ﬂexible tube (~30 cm). All instruments
were operated simultaneously at a sampling frequency of 1 s, and the sample
ﬂows were 10, 5, and 0.3 l/min for the FMPS, APS, and CPC, respectively.
Theoretical mass concentrations were calculated on the basis of the FMPS and
APS measurements assuming spherical particles and densities of 1H,1H,2H,2H-
perﬂuorooctyltriethoxysiloxane (1.34 g/cm
3) and hexadecyl trimethoxysilane
(0.89 g/cm
3) for NFP 1 and NFP 2, respectively (Table 1).
Finally, the mass concentration of the particle exposure was quantiﬁed by
ﬁlter sampling using Millipore Teﬂon with a pore size of 0.45 lm (Millipore
Co., Billerica, MA) at an air ﬂow of 2 l/min for 2–36 min. Differential weighing
of the ﬁlters was carried out on a Sartorius Microscale Model M3P (Sartorius
GmbH, Go ¨ttingen, Denmark) after 24 h of acclimatization (humidity 50 ± 2.5%,
20 C ± 0.2) before and after ﬁlter exposure.
Collection of respiratory parameters. The Notocord Hem (Notocord
Systems SA, Croissy-sur-Seine, France) data acquisition software was used to
collect respiratory parameters. For each experiment, up to 10 mice were placed
in body plethysmographs in the exposure chamber, and animals were exposed
head-only (Vijayaraghavan et al., 1994). The acquisition program calculates
inter alia the respiratory frequency (breaths/minute), time of inspiration
(milliseconds), time of expiration (milliseconds), time from end of inspiration
until the beginning of expiration, termed time of brake (milliseconds), time
from end of expiration until beginning of the next inspiration, termed time of
pause (milliseconds), tidal volume (VT, milliliters), and midexpiratory ﬂow rate
(milliliters/second). Comprehensive descriptions of the breathing parameters
have been made elsewhere (Alarie, 1998; Larsen et al., 2000; Nielsen et al.,
1999; Vijayaraghavan et al., 1994). Data acquisition and calculations were
performed as described previously (Larsen et al., 2004).
Acute airway irritation. To assess the airway irritation effects of the
two NFPs, groups of mice (n ¼ 7–19) were exposed for 60 min to
concentrations of NFP 1 ranging from 3.3 to 42.4 mg/m
3 and NFP 2 from 33.2
to 60 mg/m
3, respectively, see Table 1. The 60-min exposure period was
followed by a 30-min recovery period in which the mice were exposed to
laboratory air.
Prior to exposure, a 15-min baseline period was recorded for each mouse. To
assess the exposure-related effects, the respiratory parameters during exposure
were compared with baseline levels, i.e., each mouse served as its own control.
The reversibility of the effects on the respiratory tract was assessed by
collection of the respiratory parameters 22–24 h after cessation of the exposure
to the NFPs.
Bronchoalveolar lavage procedure. After collection of postexposure
respiratory parameters, bronchoalveolar lavage (BAL) was performed by
ﬂushing the lungs four times with 0.8 ml of saline (0.9%) using a tracheal
cannula. The recovered BALFs were pooled and centrifuged (500 3 g, 10 min,
4 C). The supernatant was discharged, and the pellet was resuspended in
a 200-ll phosphate-buffered saline containing heparin (20 IE/ml) and serum
albumin (0.003%). The total number of cells was determined using a
hemocytometer (Merck Eurolab). For differential counts, cytospin preparations
were made (Cytospin2; StatSpin Inc., Norwood, MA) (55 3 g, 4 min, room
temperature). Slides were stained with May-Gru ¨nwald/Giemsa, and all slides
were inspected by the same technician. Cells were identiﬁed by standard
morphology and differentiated into neutrophils, eosinophils, epithelial cells,
lymphocytes, and macrophages. For each slide, 200 cells were differentiated
and the total cell count of each cell type was calculated.
The BALF supernatants were analyzed for content of protein by means of
the bicinchoninic acid Protein Assay Kit. The operating procedure provided by
the manufacturer (Pierce, Rockford, IL) was followed.
Histology. In separate groups of mice (n ¼ 9–10 per group), the lungs
were ﬁxed in situ, without preceding BAL procedure. The chests of the mice
were opened and a polyethylene tube introduced into the trachea. The
polyethylene tube was connected to a syringe containing 4% buffered
paraformaldehyde, and the lungs were inﬂated with the ﬁxative to normal
size. After 5 min, the lungs were removed in toto and further ﬁxated for at least
24 h. Tissues were embedded in parafﬁn in a standardized way (horizontal cut
through the hilum regions), and subsequently, 7 lm–thick slices were cut and
stained with periodic acid-schiff hematoxylin. The degree of inﬂammation and
morphological changes in the lungs were evaluated blindly and independently
by two researchers. In case of discrepancy, the slide was reassessed.
FIG. 2. Particle number size distribution spectra of NFP 1 and 2, synth NFP 1:0.75, perﬂuorodisiloxane, and the two solvents (2-propanol and ethanol) used in
NFP 1 and NFP 2. The spectra of NFP 1 and NFP 2 were measured using both the FMPS and the APS. All other spectra were only measured using the FMPS. All
data are presented at an inlet ﬂow of 0.05 ml/min. Vertical bars indicate SDs.
AIRWAY EXPOSURES TO NANOFILM SPRAY PRODUCTS 219FIG. 3. Mice were exposed 15 min to laboratory air followed by a 60-min exposure to NFP 1 (a), NFP 2 (b), or NFP-related substances (c). In the recovery
period, mice were allowed to breathe laboratory air for 30 min after the exposure. Respiratory parameters are VT. The vehicle control groups are depicted with their
95% conﬁdence intervals. For clarity, only a limited number of representative time-response curves are shown. Exposure concentrations (milligrams/cubic meter)
are given for NFP 1 and 2 (a and b, respectively).
220 NØRGAARD ET AL.Statistics. The effects of the NFPs on the respiratory parameters were
compared with effects from the solvent controls. Statistical signiﬁcance was
accepted if the response induced by NFP exposure was not included in the 95%
conﬁdence interval of the vehicle control animals (cf. Fig. 3). In order to
minimize the number of statistical tests, Kruskal-Wallis tests were applied to
evaluate exposure-dependent effects on body weights, BAL cell counts, and
protein in BALFs, respectively. If statistically signiﬁcant differences were
found (p < 0.05), data were further analyzed by the Mann-Whitney’s U-test.
Data in the NFP groups were compared pairwise with the corresponding
responses in the vehicle control animals by means of the Mann-Whitney’s
U-test. A signiﬁcant difference was accepted at p levels below 0.05. Calculations
were performed using the Minitab Statistical Software, Release 14 Xtra
(Minitab Inc., PA).
RESULTS
Exposure Characterization
Table 1 summarizes inlet ﬂow rates and the corresponding
particle number and mass concentrations in the exposure
chamber. The CPC, FMPS, and APS particle number and mass
concentrations all increased linearly (R
2 > 0.96) with increased
inlet concentrations. Therefore, particle numbers and particle
size distributions were estimated by extrapolation by means of
linear regression analysis above the saturation level of the
instruments (inlet ﬂows above 0.1 ml/min). By number, the
exposure concentrations were comparable for the two tested
NFPs and chemicals ranging from 1.6 3 10
5 to 1.4 3 10
7
particles/cm
3 (FMPS þ APS) at inlet ﬂows of 0.01 to 0.5 ml/min
liquid product. The FMPS measured slightly higher
concentrations than the CPC (~1.4 3 10
5 to 4.6 3 10
6
particles/cm
3).
Gravimetric measurements showed a range in exposure
concentrations from 3.3 to 42.4 mg/m
3 for NFP 1 and from 1.1
to 60 mg/m
3 for NFP 2. For NFP 1, the theoretical mass
concentrations calculated from FMPS and APS data correlated
with the gravimetric measurements (ﬁlter mass ¼ 0.97 3
calculated mass; r
2 ¼ 0.99). The correlation in the case of
NFP 2 was as follows: ﬁlter mass ¼ 1.4 3 calculated mass;
r
2 ¼ 0.96 (Table 1). Filter sampling of synth NFP 1:0.75
resulted in a particle concentration of 46.3 ± 0.4 mg/m
3 (inlet
ﬂow: 0.5 ml/min). This agrees with 42.4 ± 1.1 mg/m
3 measured
for NFP 1 at the same inlet ﬂow. Perﬂuorosilane and
perﬂuorodisiloxane could not be sampled quantitatively by
collection on ﬁlters because of their volatility. Thus, these data
are absent in Table 1.
FIG. 4. Cells in BALF. Mice were lavaged by 4 3 0.8 ml saline 24 h after exposure to NFPs (a) or NFP-related substances (b). Bars are mean values with
SEM. Group sizes are given in Table 2. Statistical signiﬁcant differences from vehicle control groups are indicated by *p < 0.05, **p < 0.01, or ***p < 0.001.
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those of synthesized NFP 1, bis(1H,1H,2H,2H-perﬂuorooctyl)
tetramethyldisiloxane, and the two NFP solvents (2-propanol
and ethanol) are shown in Figure 2. All particle spectra are
shown for an inlet ﬂow rate of 0.05 ml/min.
It is clear that the NFPs generate characteristic size
distributions with strong contributions of particles larger than
20 nm. NFP 1 produces smaller particles (peak size ¼ 60.4 nm)
than NFP 2 (peak size ¼ 124 nm). Both NFPs also appear to
produce a small mode ~10 and ~34 nm. The contribution of
particles from 2-propanol and ethanol is minor, which
is dominated by sizes below 200 nm with a peak in
particle concentration at ~10 and ~34 nm. Consequently, the
10- to 34-nm particles found in the two commercial NFPs may
be ascribed to residuals from the solvents. By number, the
particle contributions reached from spraying pure solvents were
2.9 3 10
4 to 4.7 3 10
4 particles/cm
3 as compared with
1.4 3 10
6 to 1.6 3 10
6 particles/cm
3 spraying NFP 1 and NFP
2, respectively (all at inlet ﬂows of 0.05 ml/min).
Acute Airway Effects
Exposure to the ﬂoor sealant, NFP 1. A signiﬁcant
concentration-dependent decrease of the VT was observed
during exposure (Fig. 3). Onset of the VT response occurred
faster at higher concentrations and developed gradually. Above
16.1 mg/m
3, the VT reached the same plateau after 60 min of
exposure. This indicates an abrupt response with a very steep
exposure-response relationship. The response did not resolve
during the 30-min recovery period. No clear exposure-
dependent effect was seen on the respiratory rate (data not
shown). Furthermore, the time of brake and the time of pause
were unaffected, i.e., neither sensory nor pulmonary irritation
was apparent from the respiratory tract (data not shown).
One day after the exposure, VT was still signiﬁcantly
suppressed in the 18.4 mg/m
3 group. Several mice in the 24.4
and42.4mg/m
3groupswereinamoribundstateandconsequently
euthanized few hours after the exposure, why respiratory data
are unavailable from these mice 1 day after NFP exposure.
Exposure to tile coating, NFP 2. Only the highest exposure
concentration, 60 mg/m
3, gave rise to VT effects that were
statistically signiﬁcantly different from the vehicle control
group. The effect was, however, relatively weak and reversible
(cf. Fig. 3b).
Exposure to perﬂuorosilane and perﬂuorodisiloxane. Ex-
posure to these compounds gave rise to little or no effect on the
pulmonary function. Reductions in VT did, only to a limited
extent, differ from the 95% conﬁdence interval for the solvent
control group, see Figure 3c. Furthermore, no effect was seen
the day after the exposure.
Exposure to synthesized perﬂuorosilane. A gradual de-
crease in VT was seen after exposure to synthesized
perﬂuorosilane with 0.5, 0.75, and 1.0 mol of water added
for each hydrolyzable group (designated synth NFP 1: 0.5,
0.75, and 1.0, respectively). Exposure to synth NFP 1:0.5 gave
rise to an ~40% reduction in VT, whereas synth NFP 1:0.75
reduced the VT by ~55% (cf. Fig. 3). For both synth NFP 1:0.5
and synth NFP 1:0.75, the effect on VT was, at least in part,
reversible (Fig. 3c). Exposure to synth NFP 1:1.0 gave rise to
signiﬁcant depression in the VT almost immediately after the
onset of exposure. The exposure was abrogated after 30 min.
At this time point, the mice were severely affected, and the
exposure was discontinued for ethical reasons.
Inﬂammatory cells and proteins in BALF. Exposure to
NFP 1 induced neutrophilic as well as lymphocytic lung
inﬂammation that reached signiﬁcantly increased numbers at an
exposure to 18.4 mg/m
3 (2.3 3 10
6 particles/cm
3)( Fig. 4a).
Although the number of macrophages was increased in the
lowest NFP 1 exposure group (3.3 mg/m
3), the number of
macrophages did not differ from the control group at higher
exposure concentrations. Mice exposed to 24.4 or 42.4 mg/m
3
were euthanized few hours post exposure to avoid unnecessary
suffering; thus, no BAL data were obtained. No effects were
seen on BAL cell numbers after exposure to NFP 2.
Mice exposed to perﬂuorosilane had increased number of
lymphocytes (Fig. 4b). Exposure to synthesized perﬂuorosilane
induced increased number of neutrophils, lymphocytes, and
TABLE 2
Effects of Exposure on Body Weight and Protein in BALF
Exposure
Number of
mice in
group
Dm 22–24 h
a
(wt%)
Protein in
BALF
(lg/ml)
NFP 1 solvent control (2-propanol) (mg/m
3)
1 10 0.2 ± 1.0 163 ± 54
NFP 1 (mg/m
3)
3.3 9 0.5 ± 1.2 ND
15.7 19 1.3 ± 1.2* 143 ± 119
16.1 10 2.3 ± 1.4** 133 ± 76
18.4 7 9.1 ± 3.9*** 1153 ± 856**
NFP 2 solvent control (ethanol) (mg/m
3)
1.5 10 2.0 ± 1.0 118 ± 71
NFP 2 (mg/m
3)
33.2 10 0.5 ± 1.5* 207 ± 136
60.0 20 1.3 ± 0.9 144 ± 70
Perﬂuorodisiloxane (mg/m
3)
26.5 10 1.3 ± 1.2 165 ± 48
Perﬂuorosilane (mg/m
3)
1.8 8 2.0 ± 2.0 156 ± 44
Synth NFP 1
b
NFP 1:0.5
c 8  0.1 ± 1.4 —
NFP 1:0.75 46.3 mg/m
3 10 9.5 ± 2.2*** 893 ± 311***
NFP 1:1.0
c 10 8.5 ± 1.1*** 743 ± 187***
Note. ND, not done.
Statistical signiﬁcant differences from solvent control groups are indicated
by *p < 0.05, **p < 0.01, or ***p < 0.001.
aLoss in body weight (% with SD) 22–24 h post exposure.
bInlet ﬂows were 0.5 ml/min in all tests with Synth NFP 1.
cNo ﬁlter measurement.
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perﬂuorodisiloxane. Regarding total protein, increased levels
were seen in BALFs from mice exposed to 18.4 mg/m
3 NFP 1,
synth NFP 1:0.75, and synth NFP 1:1.0 (Table 2).
Body weight. Exposure to NFP 1 gave rise to concentration-
dependent decreases in body weight. Body weights were
signiﬁcantly reduced in mice exposed to 15.7 mg/m
3 or more
NFP 1 (Table 2). Furthermore, signiﬁcantly reduced body
weights were seen in mice exposed to synth NFP 1:0.75 and
synth NFP 1:1.0 (cf. Table 2). No changes in body weights
were seen in mice exposed to NFP 2.
Histological examination of lung tissue. The most exten-
sive morphological damage was observed in the group exposed
to NFP 1. Typical ﬁndings were emphysema-like morpholog-
ical changes probably secondary to overdistension caused by
atelectasis (Figs. 5A and 5B). Moreover, there were hemor-
rhages both in the alveoli and in the bronchioles (Fig. 5C) and
damage to the type 1 pneumocytes. Particles from inhaled NFP
1 could be observed as brown deposits in the alveoli, either free
in the lumen or taken up by alveolar or interstitial macrophages
(Fig. 5D). In the bronchioles, the Clara cells had an ‘‘empty’’
appearance, suggesting the release of stored mucin.
DISCUSSION
A number of severe cases of lung injuries have been
associated with the use of spray sealing products (e.g., Pauluhn
et al., 2008; Vernez et al., 2006). However, the causative
agents have not yet been identiﬁed. It has been suggested that
the mechanism of action could be related to alteration of
surface tension of the lung lining ﬂuid by perﬂuorinated
polymers (cf. Vernez et al., 2006). Thus, to investigate the
effect of perﬂuorination, we have measured the lung effects
from two different NFPs, one with perﬂuorinated silanes/
alkylsiloxanes (NFP 1) and another with nonﬂuorinated
alkylsilanes/alkylsiloxanes (NFP 2).
A single 60-min exposure to NFP 1 at concentrations of
18.4 mg/m
3 and above induced a prominent impairment of the
lung function in mice; this effect was not reversible over
a period of 1 day. The effect was concentration dependent with
a narrow window between no–observed effect level and lethal
concentration. Similar effects could be observed for synthe-
sized NFP 1, and the degree of hydrolysis of the ﬂuorosilane
was found to be a critical factor.
Experiments with 0.5, 0.75, and 1.0 mol water added for
each hydrolyzable group in the ﬂuorosilane showed signiﬁcant
increases of the toxic effects mimicking the effects of NFP 1.
Thus, the effect appears to depend on the degree of hydrolysis
forming free hydroxyl groups in the ﬁnal product. This is also
supported by the absence of effect from the nonhydrolyzed
perﬂuorosilanes 1H,1H,2H,2H-perﬂuorooctyl triethoxysilane
and bis-(1H,1H,2H,2H-perﬂuorooctyl) tetramethyldisiloxane
and NFP 2.
Our study suggests that a combination of perﬂuorination and
the number of free hydroxyl groups determines the toxicity of
FIG. 5. Histological examination of lungs ﬁxed with formalin 22–24 h after exposure to NFP 1 (42.4 mg/m
3). The observations were atelectasis (A),
emphysema (B), and hemorrhage in the alveoli and bronchioles (C), and deposits of NFP in the alveoli, either free in the lumen or taken up by macrophages (D).
AIRWAY EXPOSURES TO NANOFILM SPRAY PRODUCTS 223NFP 1. Furthermore, protein in BALF was highly increased
after exposure to NFP 1, indicating a toxic effect on the lung
tissue. Furthermore, animals exposed to NFP 1 lost up to 10%
of their body weight within the ﬁrst 24 h after exposure, which
suggests that the general health of the animals was consider-
ably affected. The toxicity of NFP 1 was further conﬁrmed by
histological examination of the lung tissue. Inhalation of NFP 1
gave rise to atelectasis (collapsed alveoli), hemorrhage, and
emphysema or lung overdistension because of maldistribution
of ventilation. The effects gave rise to severely reduced lung
function.
In conclusion, inhalation of nanoﬁlm ﬂoor-sealing product
with perﬂuorosilane induced acute and severe lung damage in
mice. The degree of hydrolysis/condensation process is critical.
Before a risk assessment of aerosolized surface-coating pro-
ducts can be carried out, it is warranted to investigate the
underlying chemical and toxicological mechanisms that are
responsible for the lethal lung effect.
For consumer protection, the results of our study highlight
the relevance of taking the application procedure into account
when assessing health aspects related to the use of spray
products.
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